Inhibrx Biosciences (INBX) Assets (2023 - 2026)
Powered by 
Analysis
Inhibrx Biosciences (INBX) Assets (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Inhibrx Biosciences | 1.45 Bn | 882.42 Mn | - | 154.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154.22 Mn |
| Dec 31, 2025 | 146.48 Mn |
| Sep 30, 2025 | 177.47 Mn |
| Jun 30, 2025 | 212.12 Mn |
| Mar 31, 2025 | 242.64 Mn |
| Dec 31, 2024 | 180.77 Mn |
| Sep 30, 2024 | 222.56 Mn |
| Jun 30, 2024 | 258.42 Mn |
| Dec 31, 2023 | 307.89 Mn |
API Access
Inhibrx Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=INBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "INBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=INBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();